We provide deep domain expertise across medical devices and motorsport assets
Healix Capital Partners was founded to help private equity investors, founder-led businesses, corporates, and boards navigate complex strategic and financial decisions ahead of transactions. Our work spans strategy, investor readiness, valuation, and capital allocation.
We focus exclusively on the Medical Technology and Motorsport sectors.
In Medical Technology (“MedTech”), we advise across medical devices, diagnostics, tools, and selected healthcare services. The sector remains highly fragmented and rapidly evolving, requiring deep commercial insight and specialist expertise to navigate effectively.
Motorsport is attracting increasing interest from financial sponsors, driven by consolidation opportunities, global audience growth, and scalable commercial platforms.
Drawing on extensive sector experience and hands-on industry knowledge, we provide clients with clear, independent strategy and exit advice where traditional advisor perspectives often lack depth or sector specificity — helping clients make better-informed decisions while avoiding costly ones.
“Risk comes from not knowing what you’re doing.”
Career Heighlights
We specialise in the most fragile and high-stake phase-before a transaction - where strategic framing determines valuation and outcomes
We understand how strategy, markets, valuation and execution connect across the entire capital lifecycle
We bring a genuinely global lens to strategy and valuation – not a single market perspective
We combine institutional quality-grade rigour with transaction and corporate decision-making experience
Michael Jüngling is a MedTech veteran, having specialised in the sector since the late 1990’s. Having worked out of London, New York and Sydney, he has a global perspective. Furthermore, with experience in audit, equity research and investment banking, he has a unique set of experiences to understand the eco-system of private and public investing, including what drives company desirability and valuation.
